New subsidiary should enable the Company to speed-up growth
in European markets
MONTREAL,
Aug. 14, 2012 /CNW Telbec/ - Clemex
Technologies Inc. (TSXV: CXG.A) is pleased to announce the opening
of its subsidiary "Clemex Europe" in France. This new subsidiary will be owned
jointly by Clemex Technologies Inc. (75%) and RAL Diagnostics
(25%). It will be located in Martillac (Bordeaux) and operated from the office
premises of RAL Diagnostics.
This expansion in Europe is in accordance with both Clemex and
RAL Diagnostics strategic development plans outlined after their
partnership agreement was signed last year. For several years, the
Company had hoped to expand in Europe to further develop growth on that
market. The expansion of operations had become essential with the
new medical instruments designed for the biomedical field.
When asked to comment, president and CEO, Mr.
Clement Forget stated "We are very
pleased to finally have permanent physical presence in France. The European market has excellent
commercial development potential for all products designed by
Clemex. There is a very important European clientele which have to
same needs and demands as our North American clients. However, we
have never been able to serve the demands on this market as well as
we could with no qualified sales representatives physically present
in Europe. Along with our new
partner, RAL Diagnostics, we have set the grounds necessary to
expand with confidence, hence, obtain business development on this
market which should meet our goals."
Mr. Frédéric Imbs, president and general manager
of RAL Diagnostic has declared on his part "The opportunity to have
the Clemex products and Clemex expertise will be greatly helpful
for us in continuing our joint effort to, design, build,
manufacture, and sell our products destined to the biomedical
market. Combining our efforts and strengths, we have concluded a
win-win arrangement, that can only be mutually beneficial to both
companies."
About RAL Diagnostics
RAL Diagnostics is a manufacturer of biological
stains intended for the field of human and animal health,
scientific research, medical diagnosis, and industry. These stains
are available in liquids or ready to use kits. RAL Diagnostics
serves 6,000 medical analysis laboratories and anatomopathology
laboratories of France thanks to a
network of 35 distributors and 180 representatives. The company is
present in more than 40 countries in the world.
About Clemex Technologies, Inc.
Clemex Technologies Inc. develops, manufactures
and markets image analysis systems and software used by quality
control and research microscopy laboratories. Clemex customer
base spans over many countries in America, Europe, Asia
and encompasses major Research and Development Centers, prestigious
Universities and large manufacturing industries in various fields
including healthcare, automotive, aerospace, raw materials
manufacturing, pharmaceuticals, mining and other sectors.
The TSX Venture Exchange has not reviewed and
does not accept responsibility for the adequacy and accuracy of
this news release.
SOURCE CLEMEX TECHNOLOGIES INC.